Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

PURPOSE: Accurate assessments of recurrence risk and absolute treatment benefit are needed to inform colon cancer adjuvant therapy. The 12-gene Recurrence Score assay has been validated in patients with stage II colon cancer from the Cancer and Leukemia Group B 9581 and Quick and Simple and Reliable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yothers, Greg, O'Connell, Michael J., Lee, Mark, Lopatin, Margarita, Clark-Langone, Kim M., Millward, Carl, Paik, Soonmyung, Sharif, Saima, Shak, Steven, Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871512/
https://ncbi.nlm.nih.gov/pubmed/24220557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.47.3116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados